Evidence map›Paper›PMID 36645278›Full record

ArticlemSphere2023

Combination of 2-

Junsheng Liu, Zengyan Chang, Xiaosa Chang, Junjian Li, Ulrich Glebe, Ai-Qun Jia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Junsheng Liu *Key Laboratory of Tropical Biological Resources of Ministry of Education, One Health Institute, Hainan University, Haikou, China.
Zengyan Chang *Key Laboratory of Tropical Biological Resources of Ministry of Education, One Health Institute, Hainan University, Haikou, China.
Xiaosa ChangSchool of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Junjian LiSchool of Pharmaceutical Sciences, Hainan University, Haikou, China.
Ulrich GlebeInstitute of Chemistry, University of Potsdam, Potsdam-Golm, Germany.
Ai-Qun JiaKey Laboratory of Tropical Biological Resources of Ministry of Education, One Health Institute, Hainan University, Haikou, China.ORCID 0000-0002-8089-6200
Hainan University · CNUniversity of Potsdam · DEWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-resistant bacteria have been raising serious social problems. Bacterial biofilms and different virulence factors are the main reasons for persistent infections. As a conditioned pathogen, Chromobacterium violaceum has evolved a vast network of regulatory mechanisms to modify and fine-tune biofilm development, contributing to multidrug resistance. However, there are few therapies to combat drug-resistant bacteria. Quorum sensing (QS) inhibitors (QSIs) are a promising strategy to solve antibiotic resistance. Our previous work suggested that 2-

Indexed as

Zinc OxideAnimalsBacteriaBenzoquinonesBiofilmsCaenorhabditis elegansChromobacteriumQuorum SensingVirulence Factors2-tert-butyl-4-quinoneBenzoquinonesVirulence FactorsZinc Oxide2-tert-butyl-1,4-benzoquinonebiofilmChromobacterium violaceumquorum sensing inhibitorZnO nanoparticles

Identifiers

PMID36645278
PMCPMC9942565
OpenAlexW4316663003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.